abstract |
The present invention relates to a compound of formula (I); pharmaceutical compositions comprising said compounds; a method of treating COVID-19 in a patient by administration of a therapeutically effective amount of said compound; It relates to a method of inhibiting or preventing the replication of SARS-CoV-2 by said compound: [Formula I] wherein R 1 , R 2 and ----- are as defined herein. |